rolofylline has been researched along with 1,3-dipropyl-8-cyclopentylxanthine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (69.23) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichikawa, S; Ishii, A; Nonaka, H; Ono, E; Shimada, J; Shiozaki, S; Suzuki, F | 1 |
| Ishii, A; Karasawa, A; Kawakita, T; Kubo, K; Mizumoto, H; Nonaka, H; Shimada, J; Suzuki, F | 1 |
| Ishii, A; Nonaka, H; Shimada, J; Suzuki, F | 1 |
| Jacobson, KA; van Galen, PJ; Williams, M | 1 |
| Baker, SP; Belardinelli, L; Lee, G; Linden, J; Lum, RT; Milner, P; Pfister, JR; Schreiner, G; Stanley, WC | 1 |
| Bondavalli, F; Botta, M; Bruno, O; Ciacci, A; Corelli, F; Fossa, P; Lucacchini, A; Manetti, F; Martini, C; Menozzi, G; Mosti, L; Ranise, A; Schenone, S; Tafi, A; Trincavellic, ML | 1 |
| El-Tayeb, A; Inamdar, GS; Li, W; Müller, CE; Scheiff, AB; Sudarsanam, V; Vasu, KK; Yerande, SG | 1 |
| Batuman, V; Cai, H; Guan, S; Puschett, DB; Puschett, JB | 1 |
| Karasawa, A; Mizumoto, H | 1 |
| Brause, M; Delabar, U; Eckardt, KU; Gleiter, CH; Zebski, H | 1 |
| Habu, Y; Hashimoto, Y; Inui, K; Katsura, T; Nagai, J; Yano, I | 1 |
| Dubey, RK; Forman, MB; Jackson, EK; Murray, JJ; Velasco, CE; Vitola, JV | 1 |
| Diekmann, M; Fülle, F; Hinz, S; Klotz, KN; Müller, CE; Schumacher, B; Weyler, S | 1 |
1 review(s) available for rolofylline and 1,3-dipropyl-8-cyclopentylxanthine
| Article | Year |
|---|---|
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
Topics: Adenosine; Animals; Humans; Models, Chemical; Receptors, Purinergic; Second Messenger Systems; Structure-Activity Relationship | 1992 |
12 other study(ies) available for rolofylline and 1,3-dipropyl-8-cyclopentylxanthine
| Article | Year |
|---|---|
7,8-Dihydro-8-ethyl-2-(3-noradamantyl)-4-propyl-1H-imidazo[2,1-i]purin-5(4H)-one: a potent and water-soluble adenosine A1 antagonist.
Topics: Adamantane; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Guinea Pigs; Hemodynamics; Imidazoles; Purinergic Antagonists; Purinones; Rats; Receptors, Purinergic; Solubility; Vasodilator Agents | 1992 |
Adenosine A1 antagonists. 2. Structure-activity relationships on diuretic activities and protective effects against acute renal failure.
Topics: Acute Kidney Injury; Adenosine; Animals; Cations, Monovalent; Diuretics; Male; Potassium; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Purinergic; Sodium; Structure-Activity Relationship; Xanthines | 1992 |
8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding, Competitive; Cell Membrane; Corpus Striatum; Guinea Pigs; Humans; Molecular Conformation; Molecular Structure; Prosencephalon; Purinergic Antagonists; Rats; Receptors, Purinergic; Stereoisomerism; Structure-Activity Relationship; Xanthines | 1992 |
Synthesis and biological evaluation of the enantiomers of the potent and selective A1-adenosine antagonist 1,3-dipropyl-8-[2-(5,6-epoxynorbonyl)]-xanthine.
Topics: Animals; Diuresis; Guinea Pigs; Humans; Models, Molecular; Molecular Structure; Purinergic P1 Receptor Antagonists; Rats; Receptors, Purinergic P1; Stereoisomerism; Structure-Activity Relationship; Xanthines | 1997 |
Synthesis, molecular modeling studies, and pharmacological activity of selective A(1) receptor antagonists.
Topics: Animals; Binding, Competitive; Cattle; Cerebral Cortex; Ligands; Models, Molecular; Purinergic P1 Receptor Antagonists; Pyridines; Radioligand Assay; Receptors, Purinergic P1; Structure-Activity Relationship | 2002 |
2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists.
Topics: Adenosine A1 Receptor Antagonists; Animals; Drug Design; Humans; Molecular Structure; Rats; Receptor, Adenosine A1; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 2010 |
Phosphate transport inhibition by KW-3902, an adenosine A1 receptor antagonist, is mediated by cyclic adenosine monophosphate.
Topics: Animals; Biological Transport; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Female; Kidney Tubules, Proximal; Parathyroid Hormone; Phosphates; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Xanthines | 1995 |
Effects of adenosine A1-agonist and -antagonist on urinary volume and Na excretion in IAP-treated and non-treated rats.
Topics: Animals; Diuresis; Diuretics; Glomerular Filtration Rate; Male; Pertussis Toxin; Phenylisopropyladenosine; Rats; Rats, Wistar; Receptors, Purinergic P1; Sodium; Virulence Factors, Bordetella; Xanthines | 1993 |
Evidence against a major role of adenosine in oxygen-dependent regulation of erythropoietin in rats.
Topics: Adenine; Adenosine; Adenosine Diphosphate; Animals; Antihypertensive Agents; Carbon Monoxide; Dipyridamole; Diuretics; Drug Synergism; Enzyme Inhibitors; Erythropoietin; Gene Expression; Hypoxia; Kidney; Male; Oxygen; Phenethylamines; Phosphodiesterase Inhibitors; Piperazines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; RNA, Messenger; Theophylline; Vasodilator Agents; Xanthines | 1997 |
Inhibitory effect of KW-3902, an adenosine A(1) receptor antagonist, on p-aminohippurate transport in OK cells.
Topics: Adenosine Deaminase; Animals; Anion Transport Proteins; Biological Transport; Carbon Radioisotopes; Carrier Proteins; Cell Line; Ketoglutaric Acids; Kinetics; p-Aminohippuric Acid; Purinergic P1 Receptor Antagonists; Staurosporine; Xanthines | 1999 |
Sustained reduction in myocardial reperfusion injury with an adenosine receptor antagonist: possible role of the neutrophil chemoattractant response.
Topics: Animals; Coronary Circulation; Dogs; Female; Male; Myocardial Reperfusion Injury; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Purinergic P1 Receptor Antagonists; Xanthines | 2000 |
Improving potency, selectivity, and water solubility of adenosine A1 receptor antagonists: xanthines modified at position 3 and related pyrimido[1,2,3-cd]purinediones.
Topics: Adamantane; Adenosine A1 Receptor Antagonists; Animals; Cells, Cultured; Humans; Phosphates; Prodrugs; Rats; Solubility; Structure-Activity Relationship; Water; Xanthine; Xanthines | 2006 |